Current developments of coumarin compounds in medicinal chemistry

Current Pharmaceutical Design

Volumn 19, Issue 21, 2013, Pages 3884-3930

  Peng, Xin Mei ^a   Damu, Guri L V ^b   Zhou, Cheng He ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Antibacterial; Anticancer; Anticoagulant; Antioxidative; Biological stain; Coumarin; Probe; Supramolecular drug

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIPARASITIC AGENT; ANTIPARKINSON AGENT; ANTIVIRUS AGENT; AP 2243; AROMATASE INHIBITOR; BETA SECRETASE INHIBITOR; COUMARIN DERIVATIVE; DIAGNOSTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID AMIDASE INHIBITOR; GAMMA LACTONE DERIVATIVE; HEAT SHOCK PROTEIN 90 INHIBITOR; KU 398; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE; PYRANOCOUMARIN DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; BREAST CARCINOMA; COLON CANCER; DEPRESSION; DIABETES MELLITUS; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; FUNGAL STRAIN; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; INFLUENZA VIRUS A H1N1; LEUKEMIA; LUNG CANCER; MOLECULAR DOCKING; MYCOSIS; NONHUMAN; PANCREAS CANCER; PARASITOSIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; STOMACH CARCINOMA; STRUCTURE ACTIVITY RELATION; SUPRAMOLECULAR CHEMISTRY; UTERINE CERVIX CANCER; VIRUS STRAIN;

ANIMALS; ANTICOAGULANTS; CHEMISTRY, PHARMACEUTICAL; COUMARINS; DRUG DESIGN; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84878657077     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319210013     Document Type: Review

References (428)

1. Bairagi SH, Salaskar PP, Loke SD, Surve NN, Tandel DV, Dusara MD. Medicinal significance of coumarins. Int J Pharm Res 2012; 4: 16-9.
2. Kontogiorgis C, Detsi A, Hadjipavlou-Litina D. Coumarin-based drugs: a patent review (2008-present). Expert Opin Ther Patents 2012; 22: 437-54.
3. Mirunalini S, Krishnaveni M. Coumarin: a plant derived polyphenol with wide biomedical applications. Int J PharmTech Res 2011; 3: 1693-6.
4. Gomez-Outes A, Suarez-Gea ML, Calvo-Rojas G, et al. Discovery of anticoagulant drugs: a historical perspective. Curr Drug Discovery Technol 2012; 9: 83-104.
5. Anand P, Singh B, Singh N. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Med Chem 2012; 20: 1175-80.
6. Kostova I, Bhatia S, Grigorov P, et al. Coumarins as antioxidants. Curr Med Chem 2011; 18: 3929-51.
7. Riveiro ME, Kimpe ND, Moglioni A, et al. Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 2010; 17: 1325-38.
8. Wu L, Wang X, Xu W, Farzaneh F, Xu R. The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem 2009; 16: 4236-60.
9. Grazul M, Budzisz E. Biological activity of metal ions complexes of chromones, coumarins and flavones. Coord Chem Rev 2009; 253: 2588-98.
10. Wagner BD. The use of coumarins as environmentally-sensitive fluorescent probes of heterogeneous inclusion systems. Molecules 2009; 14: 210-37.
11. Bhatia MS, Ingale KB, Choudhari PB, Bhatia NM, Sawant RL. Application quantum and physico chemical molecular descriptors utilizing principal components to study mode of anticoagulant activity of pyridyl chromen-2-one derivatives. Bioorg Med Chem 2009; 17: 1654-62.
12. Du LP, Zhang GL, Mei D. Clinical evaluation and rational use of coumarin anticoagulants. Eval Anal Drug-use Hosp China 2008; 8: 576-9.
13. Wang H, Lu XM, Yao H, Feng JK, Liu RJ. Research progress on application of coumarin and its derivatives. Chem Ind Times 2009; 23: 40-3.
14. Schalekamp T, de Boer A. Pharmacogenetics of oral anticoagulant therapy. Curr Pharm Des 2010; 16: 187-203.
15. Howard R, Leathart JBS, French DJ, et al. Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon probes. Clin Chim Acta 2011; 412: 2063-9.
16. Correia-da-Silva M, Sousa E, Duarte B, Marques F, Cunha-Ribeiro LM, Pinto MMM. Dual anticoagulant/antiplatelet persulfated small molecules. Eur J Med Chem 2011; 46: 2347-58.
17. Kathuria A, Priya N, Chand K, et al. Substrate speci city of acetoxy derivatives of coumarins and quinolones towards calreticulin mediated transacetylation: investigations on antiplatelet function. Bioorg Med Chem 2012; 20: 1624-38.
18. Jalal S, Chand K, Kathuria A, et al. Calreticulin transacetylase: a novel enzyme-mediated protein acetylation by acetoxy derivatives of 3-alkyl-4-methylcoumarins. Bioorg Chem 2012; 40: 131-6.
19. Mladenović M, Mihailović M, Bogojević D, et al. Biochemical and pharmacological evaluation of 4-hydroxychromen-2-ones bearing polar C-3 substituents as anticoagulants. Eur J Med Chem 2012; 54: 144-58.
20. Abdelhafez OM, Amin KM, Batran RZ, Maher TJ, Nada SA, Sethumadhavan H. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives. Bioorg Med Chem 2010; 18: 3371-8.
21. Robert S, Bertolla C, Masereel B, Dogné JM, Poche L. Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors. J Med Chem 2008; 51: 3077-80.
22. Thumber BL, Vasoya VG, Desai TR, Naliapara YT, Shah KV, Tirgar PR. Anticoagulant activity of methylated coumarin derivatives. Pharmacologyonline 2011; 1010-7.
23. Ma K, Thomason LAM, McLaurin J. Scyllo-inositol, preclinical, and clinical data for Alzheimer's disease. Adv Pharmacol 2012; 64: 177-212.
24. Hargreaves RJ. "It ain't over 'til it's over"a-the search for treatments and cures for Alzheimer's disease. ACS Med Chem Lett 2012; 3: 862-6.
25. Wong KY, Duchowicz PR, Mercader AG, Castro EA. QSAR applications during last decade on inhibitors of acetylcholinesterase in Alzheimer's disease. Mini-Rev Med Chem 2012; 12: 936-46.
26. Viña D, Matos MJ, Yáñez M, Santana L, Uriarte E. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease. Med Chem Comm 2012; 3: 213-8.
27. Zhou X, Wang XB, Wang T, Kong LY. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogs. Bioorg Med Chem 2008; 16: 8011-21.
28. Izidoro da Silva J, de Moraes MC, Vieira LCC, Corrêa AG, Cass QB, Cardoso CL. Acetylcholinesterase capillary enzyme reactor for screening and characterization of selective inhibitors. J Pharm Biomed Anal 2013; 73: 44-52.
29. Leonetti F, Catto M, Nicolotti O, et al. Homo-and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors. Bioorg Med Chem 2008; 16: 7450-6.
30. Pisani L, Catto M, Giangreco I, et al. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors. ChemMedChem 2010; 5: 1616-30.
31. Citron M. Alzheimer's disease: strategies for disease modification. Nat Rev Drug Disc 2010; 9: 387-98.
32. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol 2010; 9: 702-16.
33. Torok B, Dasgupta S, Torok M. Chemistry of small molecule inhibitors in self-assembly of Alzheimer's disease related amyloidbeta peptide. Curr Bioact Comp 2008; 4: 159-74.
34. Soto-Ortega DD, Murphy BP, Gonzalez-Velasquez FJ, et al. Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorg Med Chem 2011; 19: 2596-602.
35. Marumoto S, Miyazawa M. Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor. Bioorg Med Chem 2012; 20: 784-8.
36. Wszelaki N, Paradowska K, Jamróz MK, Granica S, Kiss AK. Bioactivity-guided fractionation for the butyrylcholinesterase inhibitory activity of furanocoumarins from Angelica archangelica L. roots and fruits. J Agric Food Chem 2011; 59: 9186-93.
37. Piazzi L, Cavalli A, Colizzi F, et al. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential antialzheimer compounds. Bioorg Med Chem Lett 2008; 18: 423-6.
38. Rampa A, Bartolini M, Bisi A, et al. The first dual ChE/FAAH inhibitors: new perspectives for Alzheimer's disease. ACS Med Chem Lett 2012; 3: 182-6.
39. Pisani L, Catto M, Leonetti F, et al. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases. Curr Med Chem 2011; 18: 4568-87.
40. Leon R, Garcia AG, Marco-Contelles J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. Med Res Rev 2013; 33: 139-89.
41. Matos MJ, Viña D, Vazquez-Rodriguez S, Uriarte E, Santana L. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold. Curr Top Med Chem 2012; in press.
42. Edmondson DE, Binda C, Wang J, Upadhayay AK, Mattevi A. Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry 2009; 48: 4220-30.
43. Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 2008; 60: 1527-33.
44. Matos MJ, Viña D, Quezada E, et al. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett 2009; 19: 3268-70.
45. Matos MJ, Viña D, Picciau C, Orallo F, Santana L, Uriarte E. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett 2009; 19: 5053-5.
46. Matos MJ, Terán C, Pérez-Castillo Y, Uriarte E, Santana L, Viña D. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors. J Med Chem 2011; 54: 7127-37.
47. Matos MJ, Vazquez-Rodriguez S, Uriarte E, Santana L, Viña D. MAO inhibitory activity modulation: 3-phenylcoumarins versus 3-benzoylcoumarins. Bioorg Med Chem Lett 2011; 21: 4224-7.
48. Matos MJ, Viña D, Janeiro P, Borges F, Santana L, Uriarte E. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett 2010; 20: 5157-60.
49. Pisani L, Muncipinto G, Miscioscia TF, et al. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. J Med Chem 2009; 52: 6685-706.
50. Secci D, Carradori S, Bolasco A, et al. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. Eur J Med Chem 2011; 46: 4846-52.
51. Chimenti F, Secci D, Bolasco A, et al. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem 2009; 52: 1935-42.
52. Delogu G, Picciau C, Ferino G, et al. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. Eur J Med Chem 2011; 46: 1147-52.
53. Santana L, González-Dāaz H, Quezada E, et al. Quantitative structure activity-relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem 2008; 51: 6740-51.
54. Chen ZY, Mao RQ, Liu Y. Fullerenes for cancer diagnosis and therapy: preparation, biological and clinical perspectives. Curr Drug Metab 2012; 13: 1035-45.
55. Zhuang YY, Zhou CH, Wang YF, Li DH. Advances in the research of the alkylating anticancer agents. Chin Pharma J 2008; 44: 1281-7 (in Chinese).
56. Kapuriya N, Kakadiya R, Dong HJ, et al. Design, synthesis, and biological evaluation of novel water-soluble N-mustards as potential anticancer agents. Bioorg Med Chem 2011; 19: 471-85.
57. 5-tetrakis(2-chloroethyl)-3,4-dimethylthiophene-2,5-dicarboxamide. Acta Crystallogr Sect E: Struct Rep Online 2010; E66: o100.
58. Zhou CH, Zhang YY, Yan CY, Wan K, Gan LL, Shi Y. Recent researches in metal supramolecular complexes as anticancer agents. Anti-Cancer Agents Med Chem 2010; 10: 371-95.
59. Zhou CH, Zhang FF, Gan LL, Zhang YY, Geng RX. Research in supramolecular chemical drugs. Sci China Ser B: Chem 2009; 39: 208-52 (in Chinese).
60. Yu KG, Liu JC, Zhou CH, Diao JL, Xu T, Li DH. Synthesis of porphyrin-nitroimidazole derivatives and their radiosensitization. Chin J Med Chem 2008; 18: 414-9 (in Chinese).
61. Mi JL, Wu J, Zhou CH. Progress in anti-tumor agents: triazoles. West China J Pharm Sci 2008; 23: 84-6 (in Chinese).
62. Wang Y, Zhou CH. Recent advances in the researches of triazole compounds as medicinal drugs. Scientia Sinica Chemica 2011; 41: 1429-56 (in Chinese).
63. Meng JP, Geng RX, Zhou CH, Gan LL. Advances in the research of benzimidazole drugs. Chin J New Drugs 2009; 18: 1505-14 (in Chinese).
64. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010; 102: 680-91.
65. Jiménez-Orozco FA, Rosales AAR, Vega-López A, et al. Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity. Eur J Pharmacol 2011; 668: 35-41.
66. Scott KA, Barnes J, Whitehead RC, Stratford IJ, Nolan KA. Inhibitors of NQO1: identification of compounds more potent than dicoumarol without associated off-target effects. Biochem Pharmacol 2011; 81: 355-63.
67. Kusuma BR, Peterson LB, Zhao HP, Vielhauer G, Holzbeierlein J, Blagg BSJ. Targeting the heat shock protein 90 dimer with dimeric inhibitors. J Med Chem 2011; 54: 6234-53.
68. Du L, Mahdi F, Jekabsons MB, Nagle DG, Zhou YD. Mammea E/BB, an isoprenylated dihydroxycoumarin protonophore that potently uncouples mitochondrial electron transport, disrupts hypoxic signaling in tumor cells. J Nat Prod 2010; 73: 1868-72.
69. Radanyi C, Le Bras G, Marsaud V, et al. Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells. Cancer Lett 2009; 274: 88-94.
70. Radanyi C, Le Bras G, Messaoudi S, et al. Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90). Bioorg Med Chem Lett 2008; 18: 2495-8.
71. Zhao HP, Yan B, Peterson LB, Blagg BSJ. 3-Arylcoumarin derivatives manifest anti-proliferative activity through Hsp90 inhibition. ACS Med Chem Lett 2012; 3: 327-31.
72. Touisni N, Maresca A, McDonald PC, et al. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 2011; 54: 8271-7.
73. Supuran CT. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010; 16: 3233-45.
74. Perez-Sayans M, Garcia-Garcia A, Scozzafava A, Supuran CT. Inhibition of V-ATPase and carbonic anhydrases as interference strategy with tumor acidification processes. Curr Pharm Des 2012; 18: 1407-13.
75. Lou YM, McDonald PC, Oloumi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011; 71: 3364-76.
76. Kristiansen G, Rose M, Geisler C, et al. Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. British J Cancer 2010; 102: 1736-45.
77. Stefanachi A, Favia AD, Nicolotti O, et al. Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-rhydroxylase/ C17-20 lyase. J Med Chem 2011; 54: 1613-25.
78. Starčević Š, Kocbek P, Hribar G, Lanisnik Rižnerc T, Gobec S. Biochemical and biological evaluation of novel potent coumarin inhibitor of 17β-HSD type 1. Chemi Biolog Interact 2011; 191: 60-5.
79. Zhang SL, Damu GLV, Zhang L, Geng RX, Zhou CH. Synthesis and biological evaluation of novel benzimidazole derivatives and their binding behavior with bovine serum albumin. Eur J Med Chem 2012; 55: 164-75.
80. Tang YD, Zhang JQ, Zhang SL, Geng RX, Zhou CH. Synthesis and characterization of thiophene-derived amido bis-nitrogen mustard and its antimicrobial and anticancer activities. Chin J Chem 2012; 30: 1831-40.
81. Shams HZ, Mohareb RM, Helal MH, Mahmoud AE. Novel synthesis and antitumor evaluation of polyfunctionally substituted heterocyclic compounds derived from 2-cyano-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-acetamide. Molecules 2011; 16: 52-73.
82. You LS, Feng S, An R, Wang XH. Osthole: a promising lead compound for drug discovery from a Traditional Chinese Medicine (TCM). Nat Prod Commun 2009; 4: 297-302.
83. Tang CH, Yang RS, Chien MY, Chen CC, Fu WM. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Eur J Pharmacol 2008; 579: 40-9.
84. You LS, An R, Wang XH, Li YM. Discovery of novel osthole derivatives as potential anti-breast cancer treatment. Bioorg Med Chem Lett 2010; 20: 7426-8.
85. Zhao HP, Kusuma BR, Blaǧǧ BSJ. Synthesis and evaluation of noviose replacements on novobiocin that manifest antiproliferative activity. ACS Med Chem Lett 2010; 1: 311-5.
86. Zhao HP, Donnelly AC, Kusuma BR, et al. Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents. J Med Chem 2011; 54: 3839-53.
87. Dong YZ, Shi Q, Liu YN, Wang X, Bastow KF, Lee KH. Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl)naphthalen-1-ol derivatives as potent and selective antibreast cancer agents. J Med Chem 2009; 52: 3586-90.
88. Sashidhara KV, Rosaiah JN, Kumar M, et al. Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents. Bioorg Med Chem Lett 2010; 20: 7127-31.
89. Mao WW, Wang TT, Zeng HP, Wang ZY, Chen JP, Shen JG. Synthesis and evaluation of novel substituted 5-hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines. Bioorg Med Chem Lett 2009; 19: 4570-3.
90. Murata T, Itoigawa M, Ito C, et al. Induction of apoptosis in human leukaemia HL-60 cells by furanone-coumarins from Murraya siamensis. J Pharm Pharmacol 2008; 60: 385-9.
91. Sun B, Yuan HQ, Xi GM, Ma YD, Lou HX. Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives. Bioorg Med Chem 2009; 17: 4981-9.
92. Wang SQ, Li X, Wang XN, Wei NN, Lou HX. Coumarins from Cicuta virosa and their modulating effects onmultidrug-resistant (MDR) tumors. Phytochem Lett 2011; 4: 97-100.
93. Iranshahi M, Masullo M, Asili A, et al. Sesquiterpene coumarins from Ferula gumosa. J Nat Prod 2010; 73: 1958-62.
94. Iwasaki H, Okabe T, Takara K, Toda T, Shimatani M, Oku H. Tumor-selective cytotoxicity of benzo[c]phenanthridine derivatives from Toddalia asiatica Lam. Cancer Chemother Pharmacol 2010; 65: 719-26.
95. Vázquez R, Riveiro ME, Vermeulen M, et al. Toddaculin, a natural coumarin from Toddalia asiatica, induces differentiation and apoptosis in U-937 leukemic cells. Phytomedicine 2012; 19: 737-46.
96. Meunier B. Hybrid molecules with a dual mode of action: dream or reality? Acc Chem Res 2008; 41: 69-77.
97. Yang J, Liu GY, Dai F, et al. Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents. Bioorg Med Chem Lett 2011; 21: 6420-5.
98. Riveiro ME, Maes D, Vázquez R, et al. Towards establishing structure-activity relationships for oxygenated coumarins as differentiation inducers of promonocytic leukemic cells. Bioorg Med Chem 2009; 17: 6547-59.
99. Gazdar AF, Gao BN, Minna JD. Lung cancer cell lines: useless artifacts or invaluable tools for medical science? Lung Cancer 2010; 68: 309-18.
100. Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJH. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 2008; 66: 445-54.
101. Belluti F, Fontana G, Bo LD, Carenini N, Giommarelli C, Zunino F. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: identification of novel proapoptotic agents. Bioorg Med Chem 2010; 18: 3543-50.
102. Musa MA, Badisa VLD, Latinwo LM, Cooperwood J, Sinclair A, Abdullah A. Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines. Anticancer Res 2011; 31: 2017-22.
103. Xia Y, Fan CD, Zhao BX, Zhao J, Shin DS, Miao JY. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents A549 lung cancer cells. Eur J Med Chem 2008; 43: 2347-53.
104. Ajani OO, Obafemi CA, Nwinyi OC, Akinpelu DA. Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives. Bioorg Med Chem 2010; 18: 214-21.
105. Zheng LW, Wu LL, Zhao BX, Dong WL, Miao YJ. Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells. Bioorg Med Chem 2009; 17: 1957-62.
106. Mohareb RM, Fleita DH, Sakka OK. Novel synthesis of hydrazidehydrazone derivatives and their utilization in the synthesis of cou marin, pyridine, thiazole and thiophene derivatives with antitumor activity. Molecules 2011; 16: 16-27.
107. Chen Y, Liu HR, Liu HS, et al. Antitumor agents 292. Design, synthesis and pharmacological study of S-and O-substituted 7-mercapto-or hydroxy-coumarins and chromones as potent cytotoxic agents. Eur J Med Chem 2012; 49: 74-85.
108. Prasad KN, Xie HH, Hao J, et al. Antioxidant and anticancer activities of 8-hydroxypsoralen isolated from wampee [Clausena lansium (Lour.) Skeels] peel. Food Chem 2010; 118: 62-6.
109. Jin L, Yan CY, Gan LL, Zhou CH. New progress in study on biological activities of chalcones. Chin J Biochem Pharm 2010; 31: 358-61 (in Chinese).
110. Cheng JH, Hung CF, Yang SC, Wang JP, Won SJ, Lin CN. Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2',5'-dialkoxylchalcones as cancer chemopreventive agents. Bioorg Med Chem 2008; 16: 7270-6.
111. Sashidhara KV, Kumar A, Kumar M, Sarkar J, Sinha S. Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents. Bioorg Med Chem Lett 2010; 20: 7205-11.
112. Via LD, Gia O, Caffieri S, García-Argáez AN, Quezada E, Uriarte E. A novel tetrahydrobenzoangelicin with dark and photo biological activity. Bioorg Med Chem 2012; 20: 3603-8.
113. Hirata T, Fujii M, Akita K, et al. Identification and physiological evaluation of the components from Citrus fruits as potential drugs for anti-corpulence and anticancer. Bioorg Med Chem 2009; 17: 25-8.
114. Burlison JA, Avila C, Vielhauer G, Lubbers DJ, Holzbeierlein J, Blagg BSJ. Development of novobiocin analogs that manifest antiproliferative activity against several cancer cell lines. J Org Chem 2008; 73: 2130-7.
115. Stan SD, Kar S, Stoner GD, Singh SV. Bioactive food components and cancer risk reduction. J Cell Biochem 2008; 104: 339-56.
116. Saidu NEB, Valente S, Bana E, Kirsch G, Bagrel D, Montenarh M. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells. Bioorg Med Chem 2012; 20: 1584-93.
117. Win NN, Awale S, Esumi H, Tezuka Y, Kadota S. Novel anticancer agents, kayeassamins C-I from the power of Kayea assamica of Myanmar. Bioorg Med Chem 2008; 16: 8653-60.
118. Devji T, Reddy C, Woo C, Awale S, Kadota S, Carrico-Moniz D. Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative. Bioorg Med Chem Lett 2011; 21: 5770-3.
119. Nolan KA, Doncaster JR, Dunstan MS, et al. Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone qxidoreductase-1 (NQO1). J Med Chem 2009; 52: 7142-56.
120. Kim YA, Kong CS, Yea SS, Seo Y. Constituents of Corydalis heterocarpa and their anti-proliferative effects on human cancer cells. Food Chem Toxicol 2010; 48: 722-8.
121. Gillis AJ, Schuller AP, Skordalakes E. Structure of the tribolium castaneum telomerase catalytic subunit TERT. Nature 2008; 455: 633-7.
122. Liu XH, Liu HF, Chen J, et al. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Bioorg Med Chem Lett 2010; 20: 5705-8.
123. Kim NH, Kim SN, Oh JS, Lee S, Kim YK. Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracilresistant human gastric cancer cell line SNU620/5-FU. Biochem Biophys Res Commun 2012; 418: 616-21.
124. Donnelly AC, Mays JR, Burlison JA, et al. The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity. J Org Chem 2008; 73: 8901-20.
125. Zhang H, Zhao M, Yu TZ, Zhao YL, Fan DW, Zhang SD. Cytotoxicity evaluation of coumarin derivatives containing 4-bromophenyl or anthracene moieties. Res Chem Intermed 2012; doi: 10.1007/s11164-012-0716-5.
126. Kempen I, Hemmer M, Counerotte S, et al. 6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid derivatives in a new approach of the treatment of cancer cell invasion and metastasis. Eur J Med Chem 2008; 43: 2735-50.
127. Jin L, Tabe Y, Kimura S, et al. Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma. British J Cancer 2011; 104: 91-100.
128. Harada K, Kubo H, Tomigahara Y, et al. Coumarins as novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer. Bioorg Med Chem Lett 2010; 20: 272-5.
129. Singh RK, Lange TS, Kim KK, Brard L. A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest New Drugs 2011; 29: 63-72.
130. Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and analogs in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 2005; 12: 887-916.
131. Borges F, Roleira F, Milhazes N, Uriarte E, Santana L. Simple coumarins: privileged scaffolds in medicinal chemistry. Front Med Chem 2009; 4: 23-85.
132. Beillerot A, Rodríguez Domínguez JC, Kirsch G, Bagrel D. Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin. Bioorg Med Chem Lett 2008; 18: 1102-5.
133. Vukovic N, Sukdolak S, Solujic S, Niciforovic N. Substituted imino and amino derivatives of 4-hydroxycoumarins as novel antioxidant, antibacterial and antifungal agents: synthesis and in vitro assessments. Food Chem 2010; 120: 1011-8.
134. Hamdi N, Bouabdallah F, Romerosa A, Benhassen R. Expedious synthesis for α, β-unsaturated coumarin derivatives using boran chelates: a novel class of potential antibacterial and antioxidant agents. CRChim 2010; 13: 1261-8.
135. Hamdi N, Fischmeister C, Puerta MC, Valerga P. A rapid access to new coumarinyl chalcone and substituted chromeno[4,3-c]pyrazol-4(1H)-ones and their antibacterial and DPPH radical scavenging activities. Med Chem Res 2011; 20: 522-30.
136. Melagraki G, Afantitis A, Igglessi-Markopoulou O, et al. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur J Med Chem 2009; 44: 3020-6.
137. Morabito G, Trombetta D, Brajendra KS, et al. Antioxidant properties of 4-methylcoumarins in in vitro cell-free systems. Biochimie 2010; 92: 1101-7.
138. Gacche RN, Jadhav SG. Antioxidant activities and cytotoxicity of selected coumarin derivatives: preliminary results of a structureactivity relationship study using computational tools. J Exp Clin Med 2012; 4: 165-9.
139. Lin MH, Chou YS, Tsai YJ, Chou DS. Antioxidant properties of 5,7-dihydroxycoumarin derivatives in in vitro cell-free and cellcontaining systems. J Exp Clin Med 2011; 3: 126-31.
140. Cáleta I, Kralj M, Marjanović M, et al. Novel cyano-and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and Xray and quantitative structure-activity relationship (QSAR) analysis. J Med Chem 2009; 52: 1744-56.
141. Khoobi M, Emami S, Dehghan G, Foroumadi A, Ramazani A, Shafiee A. Synthesis and free radical scavenging activity of coumarin derivatives containing a 2-methylbenzothiazoline motif. Arch Pharm Chem Life Sci 2011; 344: 588-94.
142. Balabani A, Hadjipavlou-Litina DJ, Litinas KE, Mainou M, Tsironi CC, Vronteli A. Synthesis and biological evaluation of (2,5-dihydro-1H-pyrrol-1-yl)-2H-chromen-2-ones as free radical scavengers. Eur J Med Chem 2011; 46: 5894-901.
143. Manojkumar P, Ravi TK, Gopalakrishnan S. Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety. Eur J Med Chem 2009; 44: 4690-4.
144. Hamdi N, Passarelli V, Romerosa A. Synthesis, spectroscopy and electrochemistry of new 4-(4-acetyl-5-substituted-4,5-dihydro-1,3,4-oxodiazol-2-yl)methoxy)-2H-chromen-2-ones as a novel class of potential antibacterial and antioxidant derivatives. C R Chim 2011; 14: 548-55.
145. Gouda MA, Berghot MA, Baz EA, Hamama WS. Synthesis, antitumor and antioxidant evaluation of some new thiazole and thiophene derivatives incorporated coumarin moiety. Med Chem Res 2012; 21: 1062-70.
146. Kadhum AAH, Al-Amiery AA, Musa AY, Mohamad AB. The antioxidant activity of new coumarin derivatives. Int J Mol Sci 2011; 12: 5747-61.
147. Zhang Y, Zou BQ, Chen ZF, et al. Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives. Bioorg Med Chem Lett 2011; 21: 6811-5.
148. Roussaki M, Kontogiorgis CA, Hadjipavlou-Litina D, Hamilakis S, Detsi A. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Bioorg Med Chem Lett 2010; 20: 3889-92.
149. Panteleon V, Kostakis IK, Marakos P, Pouli N, Andreadou I. Synthesis and free radical scavenging activity of some new spiropyranocoumarins. Bioorg Med Chem Lett 2008; 18: 5781-4.
150. Mohammadi M, Yousefi M, Habibi Z, Shafiee A. Two new coumarins from the chloroform extract of Angelica urumiensis from Iran. Chem Pharm Bull 2010; 58: 546-8.
151. Khoobi M, Foroumadi A, Emami S, et al. Coumarin-based bioactive compounds: facile synthesis and biological evaluation of coumarin-fused 1,4-thiazepines. Chem Biol Drug Des 2011; 78: 580-6.
152. Ranganath YS, Harinadha BV, Sandeep G, Parameshwar R. Synthesis and evaluation of some novel furocoumarin derivatives for radical scavenging profile and cytotoxic studies. J Chem Pharm Res 2011; 3: 62-8.
153. Symeonidis T, Chamilos M, Hadjipavlou-Litina DJ, Kallitsakis M, Litinas KE. Synthesis of hydroxycoumarins and hydroxybenzo[f]-or [h]-coumarins as lipid peroxidation inhibitors. Bioorg Med Chem Lett 2009; 19: 1139-42.
154. Gabrielli L, Capitoli A, Bini D, et al. Recent approaches to novel antibacterials designed after LPS structure and biochemistry. Curr Drug Targets 2012; 13: 1458-71.
155. Zhang J, Zhang L, Li X, Xu W. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents. Curr Med Chem 2012; 19: 2038-50.
156. Finn J. Application of SBDD to the discovery of new antibacterial drugs. Methods Mol Biol 2012; 841: 291-319.
157. Zhang FF, Gan LL, Zhou CH. Synthesis, antibacterial and antifungal activities of some carbazole derivatives. Bioorg Med Chem Lett 2010; 20: 1881-4.
158. Biswas S, Brunel J-M, Dubus J-C, Reynaud-Gaubert M, Rolain JM. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti-Infect Ther 2012; 10: 917-34.
159. Peng XM, Cai GX, Zhou CH. Recent developments in azole compounds as antibacterial and antifungal agents. Curr Top Med Chem 2013; in press.
160. Upadhyay RK. Plant natural products: their pharmaceutical potential against disease and drug resistant microbial pathogens. J Pharm Res 2011; 4: 1179-85.
161. Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao XL. Quinolones: action and resistance updated. Curr Top Med Chem 2009; 9: 981-98.
162. Wang QP, Zhang JQ, Damu GLV, Wan K, Zhang HZ, Zhou CH. Synthesis and biological activities of thio-triazole derivatives as novel potential antibacterial and antifungal agents. Sci China Ser B: Chem 2012; 55: 2134-53.
163. Damu GLV, Wen QM, Cui SF, Li QX, Peng XM, Zhou CH. Coumarin-based triazole alcohols with preparation method and pharmaceutical use thereof. CN Patent 103422800 (A). 2012 Sep.
164. Damu GLV, Wen QM, Cui SF, Peng XM, Zhou CH. Coumarinbased triazole compounds with preparation method and pharmaceutical use thereof. CN Patent 103422813 (A). 2012 Sep.
165. Zhang HZ, Li QX, Yin BT, Zhou CH. 7-(6-Bromo-hex-yloxy)-4-methyl-2H-chromen-2-one. Acta Crystallogr Sect E: Struct Rep Online 2012; 68: o1709.
166. Shi Y, Zhou CH, Zhou XD, Geng RX, Ji QG. Synthesis and antimicrobial evaluation of coumarin-based benzotriazoles and their synergistic effects with chloromycin and fluconazole. Acta Pharm Sinica 2011; 46: 798-810 (in Chinese).
167. Singh SB. Pharmaceuticals: natural products and natural product models. Nat Prod Chem Biol 2012; 289-324.
168. Davin-Régli A, Bolla JM, James CE, et al. Membrane permeability and regulation of drug 'influx and eflux' in enterobacterial pathogens. Curr Drug Targets 2008; 9: 750-9.
169. Chopra I, Schofield C, Everett M, et al. Treatment of health-careassociated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis 2008; 8: 133-9.
170. Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science 2009; 325: 1089-93.
171. Saleem M, Nazir M, Ali MS, et al. Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep 2010; 27: 238-54.
172. Kuete V, Alibert-Franco S, Eyong KO, et al. Antibacterial activity of some natural products against bacteria expressing a multidrugresistant phenotype. Int J Antimicrob Agents 2011; 37: 156-61.
173. Wu N, Fu K, Fu YJ, et al. Antioxidant activities of extracts and main components of pigeonpea [Cajanus cajan (L.) Millsp.] leaves. Molecules 2009; 14: 1032-43.
174. Kong Y, Fu YJ, Zu YG, et al. Cajanuslactone, a new coumarin with anti-bacterial activity from pigeon pea [Cajanus cajan (L.) Millsp.] leaves. Food Chem 2010; 121: 1150-5.
175. Basile A, Sorbo S, Spadaro V, et al. Antimicrobial and antioxidant activities of coumarins from the roots of Ferulago campestris (Apiaceae). Molecules 2009; 14: 939-52.
176. El-Bassuony AA. Antibacterial activity of two new monoterpene coumarins from Ethulia Conyzoides. J Pharm Res 2009; 2: 582-4.
177. Acharyya S, Patra A, Bag PK. Evaluation of the antimicrobial activity of some medicinal plants against enteric bacterial with particular reference to multi-drug resistant Vibrio cholerae. Trop J Pharm Res 2009; 8: 231-7.
178. Arumugam S, Kavimani S, Kadalmani B, Ahmed ABA, Akbarsha MA, Rao MV. Antidiabetic activity of leaf and callus extracts of Aegle marmelos in rabbit. Sci Asia 2008; 34: 317-21.
179. Chakthong S, Weaaryee P, Puangphet P, et al. Alkaloid and coumarins from the green fruits of Aegle marmelos. Phytochemistry 2012; 75: 108-13.
180. Karunai Raj M, Balachandran C, Duraipandiyan V, Agastian P, Ignacimuthu S. Antimicrobial activity of ulopterol isolated from Toddalia asiatica (L.) Lam.: a traditional medicinal plant. J Ethnopharmacol 2012; 140: 161-5.
181. Muthumani P, Meera R, Devi P, et al. Chemical investigation of Toddalia asiatica Lin. and Cardiospermum halicacabum Lin. Int J Drug Form Res 2010; 1: 224-39.
182. Wang F, Xu Y, Liu JK. New geranyloxycoumarins from Toddalia asiatica. J Asian Nat Prod Res 2009; 11: 752-6.
183. Song ZW, Liu P, Yin WP, Jiang YL, Ren YL. Isolation and identi fication of antibacterial neo-compounds from the red ants of ChangBai Mountain, Tetramorium sp. Bioorg Med Chem Lett 2012; 22: 2175-81.
184. Cheenpracha S, Vidor NB, Yoshida WY, Davies J, Chang LC. Coumabiocins A-F, aminocoumarins from an organic extract of Streptomyces sp. L-4-4. J Nat Prod 2010; 73: 880-4.
185. Patel D, Kumari P, Patel NB. In vitro antimicrobial and antimycobacterial activity of some chalcones and their derivatives. Med Chem Res 2013; 22: 726-44.
186. Patel RV, Kumari P, Rajani DP, Chikhalia KH. Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl/benzothiazolyl acetamides as antimicrobial and antituberculosis agents. Med Chem Res 2013; 22: 195-210.
187. Joshi SD, Manish K, Badiger A. Synthesis and evaluation of antibacterial and antitubercular activities of some novel imidazo[2,1-b][1,3,4]thiadiazole derivatives. Med Chem Res 2013; 22: 869-78.
188. Parvez A, Meshram J, Tiwari V, et al. Pharmacophores modeling in terms of prediction of theoretical physico-chemical properties and verification by experimental correlations of novel coumarin derivatives produced via Betti's protocol. Eur J Med Chem 2010; 45: 4370-8.
189. Singh I, Kaur H, Kumar S, Kumar A, Lata S, Kumar A. Synthesis of new coumarin derivatives as antibacterial agents. Int J Chem-Tech Res 2010; 2: 1745-52.
190. Dekić V, Radulović N, Vukićević R, Dekić B, Stojanović-Radić Z, Palić R. Influence of the aryl substituent identity in 4-arylamino-3-nitrocoumarins on their antimicrobial activity. African J Pharm Pharmacol 2011; 5: 371-5.
191. Emami S, Foroumadi A, Faramarzi MA, Samadi N. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Arch Pharm Chem Life Sci 2008; 341: 42-8.
192. Kumar PV, Reddy KM, Rao VR. Synthesis of some 7-methyl-3-(2-oxo-2H-chromen-3-yl)-5H [1,3]thiazolo[3,2-a]pyrimidin-5-ones. Indian J Chem Sect B 2008; 47B: 759-63.
193. Siddiqui N, Arshad MF, Khan SA. Synthesis of some new coumarin incorporated thiazolyl semicarbazones as anticonvulsants. Acta Pol Pharm 2009; 66: 161-7.
194. Kamal A, Adil SF, Tamboli JR, Siddardha B, Murthy USN. Synthesis of coumarin linked naphthalimide conjugates as potential anticancer and antimicrobial agents. Lett Drug Des Disc 2009; 6: 201-9.
195. Arshad A, Osman H, Bagley MC, Lam CK, Mohamad S, Zahariluddin ASM. Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives. Eur J Med Chem 2011; 46: 3788-94.
196. Chimenti F, Bizzarri B, Bolasco A, et al. Synthesis and antihelicobacter pylori activity of 4-(coumarin-3-yl)thiazol-2-ylhydrazone derivatives. J Heterocycl Chem 2010; 47: 1269-74.
197. Reddy CS, Devi MV, Kumar GR, Rao LS, Nagaraj A. Synthesis and antimicrobial activity of novel 2-(aryl)-3-[5-(2-oxo-2H-3-chromenyl)-1,3-oxazol-2-yl]-1,3-thiazolan-4-ones. J Heterocycl Chem 2011; 48: 176-82.
198. Reddy CS, Rao LS, Devi MV, Kumar GR, Nagaraj A. Synthesis of some new 3-[5-(2-oxo-2H-3-chromenyl)-1,3-oxazol-2-yl]-1,3-thiazolan-4-ones as antimicrobials. Chin Chem Lett 2010; 21: 1045-8.
199. Vergara FMF, da S Lima CH, Henriques MdasGMdeO, et al. Synthesis and antimycobacterial activity of N'-[(E)-(mono-substitutedbenzylidene)]-2-pyrazinecarbohydrazide derivatives. Eur J Med Chem 2009; 44: 4954-9.
200. de Souza MVN, Pais KC, Kaiser CR, Peralta MA, Ferreira MdeL, Lourenco MCS. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. Bioorg Med Chem 2009; 17: 1474-80.
201. Candea ALP, Ferreira MdeL, Pais KC, et al. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Bioorg Med Chem Lett 2009; 19: 6272-4.
202. Cardoso SH, Barreto MB, Lourenço MCS, et al. Antitubercular activity of new coumarins. Chem Biol Drug Des 2011; 77: 489-93.
203. Farshori NN, Banday MR, Ahmad A, Khan AU, Rauf A. 7-Hydroxy-coumarin derivatives: synthesis, characterization and preliminary antimicrobial activities. Med Chem Res 2011; 20: 535-41.
204. Patel D, Patel R, Kumari P, Patel N. In vitro antimicrobial assessment of coumarin-based s-triazinyl piperazines. Med Chem Res 2012; 21: 1611-24.
205. Al-Rifai AA, Ayoub MT, Shakya AK, Abu Safleh KA, Mubarak MS. Synthesis, characterization, and antimicrobial activity of some new coumarin derivatives. Med Chem Res 2012; 21: 468-76.
206. Manvar A, Malde A, Verma J, et al. Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides. Eur J Med Chem 2008; 43: 2395-403.
207. Guo Q, Liu ML, Feng LS, et al. Synthesis and in-vitro antimycobacterial activity of fluoroquinolone derivatives containing a coumarin moiety. Arch Pharm Chem Life Sci 2011; 344: 802-9.
208. Keri RS, Hosamani KM, Reddy HS, Shingalapur RV. Synthesis, in-vitro antimicrobial and cytotoxic studies of novel azetidinone derivatives. Arch Pharm Chem Life Sci 2010; 343: 237-47.
209. Siddiqui ZN, Mohammed Musthafa TN, Ahmad A, Khan AU. Synthesis of 4-hydroxycoumarin heteroarylhybrids as potential antimicrobial agents. Arch Pharm Chem Life Sci 2011; 11: 394-401.
210. Mladenović M, Vuković N, Sukdolak S, Solujić S. Design of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents. Molecules 2010; 15: 4294-308.
211. Ronad PM, Noolvi MN, Sapkal S, Dharbhamulla S, Maddi VS. Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives. Eur J Med Chem 2010; 45: 85-9.
212. Chimenti F, Bizzarri B, Bolasco A, et al. Synthesis, selective anti-Helicobacter pylori activity, and cytotox of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Bioorg Med Chem Lett 2010; 20: 4922-6.
213. Makandar SBN, Basanagouda M, Kulkarni MV, Pranesha, Rasal VP. Synthesis, antimicrobial and DNA cleavage studies of some 4-aryloxymethylcoumarins obtained by reaction of 4-bromomethylcoumarins with bidentate nucleophiles. Med Chem Res 2012; 21: 2603-14.
214. Zhou CH, Wang Y. Recent researches in triazole compounds as medicinal drugs. Curr Med Chem 2012; 19: 239-80.
215. Zhang SL, Chang JJ, Damu GLV, et al. Novel berberine triazoles: synthesis, antimicrobial evaluation and competitive interactions with metal ions to Human Serum Albumin. Bioorg Med Chem Lett 2013; 23: 1008-12.
216. Wan K, Fang B, Wang GZ, Zhou CH. 2-Bromo-2-(5-bromo-1H-1,2,4-triazol-1-yl)-1-(2,4-difluorophenyl)ethanone. Acta Crystallogr Sect E: Struct Rep Online 2010; E66: 986.
217. Wang BG, Yu SC, Chai XY, Yan YZ, Hu HG, Wu QY. Design, synthesis and biological evaluation of 3-substituted triazole derivatives. Chin Chem Lett 2011; 22: 519-22.
218. Zhou CH, Yu KG, Meng JP, et al. Bis-benzimidazole compounds and their benzimidazoliums, preparation and medical use thereof. CN Patent 100927898 (B). 2012 Oct.
219. Shi Y, Zhou CH. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents. Bioorg Med Chem Lett 2011; 21: 956-60.
220. Montagner C, de Souza SM, Groposo C, Delle Monache F, Smania ElzaFA, Smania AJr. Antifungal activity of coumarins. Z Naturforsch C 2008; 63: 21-8.
221. Trykowska Konc J, Hejchman E, Kruszewska H, Wolska I, Maciejewska D. Synthesis and pharmacological activity of O-aminoalkyl derivatives of 7-hydroxycoumarin. Eur J Med Chem 2011; 46: 2252-63.
222. Mir AA, Mulwad VV, Trivedi GK. Synthesis and antimicrobial activity of some methyl-2-[N-coumarin-6'-yl]-3-oxo-2,3-dihydro-1H-isoindolone-5-carboxylates. J Heterocycl Chem 2010; 47: 214-8.
223. Smyth T, Ramachandran VN, Smyth WF. A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins. Int J Antimicrob Agents 2009; 33: 421-6.
224. Virsdoia V, Shaikh MS, Manvar A, et al. Screening for in vitro antimycobacterial activity and three-dimensional quantitative ttructure-activity relationship (3D-QSAR) study of 4-(arylamino)coumarin derivatives. Chem Biol Drug Des 2010; 76: 412-24.
225. Kuarm BS, Reddy YT, Madhav JV, Crooks PA, Rajitha B. 3-[Benzimidazo-and 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agents. Bioorg Med Chem Lett 2011; 21: 524-7.
226. Farag NAH, El-Tayeb W. Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents. Eur J Med Chem 2010; 45: 317-25.
227. Jadhav VB, Nayak SK, Row TNG, Kulkarni MV. Synthesis, structure and DNA cleavage studies of coumarin analogs of tetrahydroisoquinoline and protoberberine alkaloids. Eur J Med Chem 2010; 45: 3575-80.
228. Jardosh HH, Patel MP. Microwave-assisted CAN-catalyzed solvent-free synthesis of N-allyl quinolone-based pyrano[4,3-b]chromene and benzopyrano[3,2-c]chromene derivatives and their antimicrobial activity. Med Chem Res 2013; 22: 905-15.
229. Wei JJ, Jin L, Wan K, Zhou CH. Synthesis of novel D-glucosederived benzyl and alkyl 1,2,3-triazoles as potential antifungal and antibacterial agents. Bull Korean Chem Soc 2011; 32: 229-38.
230. Karlsson AJ, Flessner RM, Gellman SH, Lynn DM, Palecek SP. Polyelectrolyte multilayers fabricated from antifungal β-peptides: design of surfaces that exhibit antifungal activity against Candida albicans. Biomacromolecules 2010; 11: 2321-8.
231. Benincasa M, Pacor S, Wu W, Prato M, Bianco A, Gennaro R. Antifungal activity of amphotericin B conjugated to carbon nanotubes. ACS Nano 2011; 5: 199-208.
232. Zhang YY, Mi JL, Zhou CH, Zhou XD. Synthesis of novel fluconazoliums and their evaluation for antibacterial and antifungal activities. Eur J Med Chem 2011; 46: 4391-402.
233. Zhou CH, Mi JL, Wu J, et al. Triazole onium compound with antimicrobial activity, preparation method and medical use. CN Patent 101391985 (A). 2009 Mar.
234. Luo Y, Lu YH, Gan LL, et al. Synthesis, antibacterial and antifungal activities of novel 1,2,4-triazolium derivatives. Arch Pharm 2009; 342: 386-93.
235. Li XC, Babu KS, Jacob MR, Khan SI, Agarwal AK, Clark AM. Natural product-based 6-hydroxy-2,3,4,6-tetrahydropyrrolo[1,2-a]pyrimidinium scaffold as a new antifungal template. ACS Med Chem Lett 2011; 2: 391-5.
236. Wang Y, Damu GLV, Lv JS, Geng RX, Yang DC, Zhou CH. Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents. Bioorg Med Chem Lett 2012; 22: 5363-6.
237. Wan K, Zhang YY, Zhou CH, Zhou XD, Geng RX, Ji QG. Recent advances in antifungal fluconazole. Chin J Antibiot 2012; 37: 8-15 (in Chinese).
238. Skepper CK, Dalisay DS, Molinski TF. Synthesis and antifungal activity of (Z)-dysidazirine. Org Lett 2008; 10: 5269-71.
239. Patel D, Kumari P, Patel N. Synthesis of 3-{4-[4-dimethylamino-6-(4-methyl-2-oxo-2H-chromen-7-yloxy)-[1,3,5]triazin-2-ylamino]-phenyl}-2-phenyl-5-(4-pyridin-2-yl-piperazin-1-ylmethyl)-thiazolidin-4-one and their biological evaluation. Med Chem Res 2012; 21: 2926-44.
240. Vijaya Laxmi S, Suresh Kuarm B, Rajitha B. Synthesis and antimicrobial activity of coumarin pyrazole pyrimidine 2,4,6(1H,3H,5H)triones and thioxopyrimidine 4,6(1H,5H)diones. Med Chem Res 2013; 22: 768-74.
241. Rollinger JM, Steindl TM, Schuster D, et al. Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein. J Med Chem 2008; 51: 842-51.
242. Mishra BB, Singh DD, Kishore N, Tiwari VK, Tripathi V. Antifungal constituents isolated from the seeds of Aegle marmelos. Phytochemistry 2010; 71: 230-4.
243. Bousetla A, Zellagui A, Derouiche K, Rhouati S. Chemical constituents of the roots of Algerian Bunium incrassatum and evaluation of its antimicrobial activity. Arabian J Chem 2011; doi: 10.1016/j.arabjc.2011.01.022.
244. Kumar R, Saha A, Saha D. A new antifungal coumarin from Clausena excavate. Fitoterapia 2012; 83: 230-3.
245. Kurdelas RR, Lima B, Tapia A, et al. Antifungal activity of extracts and prenylated coumarins isolated from baccharis darwinii Hook & Arn. (Asteraceae). Molecules 2010; 15: 4898-907.
246. Lakshminarayanan B, Rajamanickam V, Subburaju T, Pradeep Rajkumar LA, Revathi H. Synthesis and antimicrobial activity of some aldehyde derivatives of 3-acetylchromen-2-one. E-J Chem 2010; 7: 400-4.
247. Zhou CH, Fang B, Gan LL. Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof. CN Patent 101323594 (B). 2011 Apr.
248. Fang B, Zhou CH, Rao XC. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents. Eur J Med Chem 2010; 45: 4388-98.
249. Parameshwar R, Ranganath YS, Babu VH, Sandeep G. Synthesis and antifungal screening of some novel coumarin linked imidazole derivatives. Res J Pharm Biolog Chem Sci 2011; 2: 514-20.
250. Radulović NS, Bogdanović GA, Blagojević PD, Dekić VS, Vukicević RD. Could X-ray analysis explain for the differing antimicrobial and antioxidant activity of two 2-arylamino-3-nitrocoumarins? J Chem Crystallogr 2011; 41: 545-51.
251. Bairagi S, Bhosale A, Deodhar MN. Design, synthesis and evaluation of Schiff's bases of 4-chloro-3-coumarin aldehyde as antimicrobial agents. E-J Chem 2009; 6: 759-62.
252. Mladenović M, Vuković N, Nićiforović N, Sukdolak S, Solujić S. Synthesis and molecular descriptor characterization of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents. Molecules 2009; 14: 1495-512.
253. Wang XL, Wang XL, Geng RX, Zhou CH. Advance in research of antimicrobial drugs with sulfamide group. Chin J New Drug 2010; 19: 30-9 (in Chinese).
254. Wei JJ, Wang Y, Wang XL, Zhou CH, Ji QG. Recent advances of 1,2,3-triazole compounds in medicinal chemistry. Chin Pharm J 2011; 46: 481-5 (in Chinese).
255. Wang XL, Wan K, Zhou CH. Synthesis of novel sulfanilamidederived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities. Eur J Med Chem 2010; 45: 4631-9.
256. Baffoe J, Hoe MY, Toure BB. Copper-mediated N-heteroarylation of primary sulfonamides: synthesis of mono-N-heteroaryl sulfonamides. Org Lett 2010; 12: 1532-5.
257. Lopez M, Drillaud N, Bornaghi LF, Poulsen SA. Synthesis of Sglycosyl primary sulfonamides. J Org Chem 2009; 74: 2811-6.
258. Basanagouda M, Shivashankar K, Kulkarni MV, et al. Synthesis and antimicrobial studies on novel sulfonamides containing 4-azidomethyl coumarin. Eur J Med Chem 2010; 45: 1151-7.
259. Lamani KSS, Kotresh O, Phaniband MA, Kadakol JC. Synthesis, characterization and antimicrobial properties of Schiff bases derived from condensation of 8-formyl-7-hydroxy-4-methylcoumarin and substituted triazole derivatives. E-J Chem 2009; 6: S239-46.
260. Abad A, Fernández-Molina JV, Bikandi J, et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol 2010; 27: 155-82.
261. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805-26.
262. Singh S, Gupta S, Singh B, Sharma SK, Gupta VK, Sharma GL. Proteomic characterization of Aspergillus fumigatus treated with an antifungal coumarin for identification of novel target molecules of key pathways. J Proteome Res 2012; 11: 3259-68.
263. Makandar SBN, Basanagouda M, Kulkarni MV, Pranesha, Rasal VP. Synthesis, antimicrobial and DNA cleavage studies of some 4-aryloxymethylcoumarins obtained by reaction of 4-bromomethylcoumarins with bidentate nucleophiles. Med Chem Res 2012; 21: 2603-14.
264. Siddiqui ZN, Musthafa TNM, Praveen S. Solvent-and catalyst-free synthesis of bis-adducts of 3-formylchromone as potential antimicrobial agents. Med Chem Res 2013; 22: 127-33.
265. Tian LW, Pei Y, Zhang YJ, Wang YF, Yang CR. 7-Omethylkaempferol and-quercetin Glycosides from the whole plant of Nervilia fordii. J Nat Prod 2009; 72: 1057-60.
266. Završnik D, Muratoviš S, Makuc D, et al. Benzylidene-bis-(4-Hydroxycoumarin) and benzopyrano-coumarin derivatives: synthesis, 1H/13C-NMR conformational and X-ray crystal structure studies and in vitro antiviral activity evaluations. Molecules 2011; 16: 6023-40.
267. Yu KG, Zhou CH, Li DH. Advances in the research of the macrocyclic agents. Chin Pharm J 2008; 43: 481-8 (in Chinese).
268. Craxi A, Laffi G, Zignego AL. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med 2008; 29: 85-95.
269. Hwu JR, Singha R, Hong SC, et al. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents. Antivir Res 2008; 77: 157-62.
270. Neyts J, Clercq ED, Singha R, et al. Structure activity relationship of new anti-hepatitis C virus agents: heterobicycle coumarin conjugates. J Med Chem 2009; 52: 1486-90.
271. Hwu JR, Lin SY, Tsay SC, Clercq ED, Leyssen P, Neyts J. Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virus. J Med Chem 2011; 54: 2114-26.
272. Mazzei M, Nieddu E, Miele M, et al. Synthesis of Mannich bases of 7-hydroxycoumarin and screened against Flaviviridae. Bioorg Med Chem 2008; 16: 2591-605.
273. Ma T, Liu L, Xue H, et al. Chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide A analogs as anti-HIV-1 agents. J Med Chem 2008; 51: 1432-46.
274. Xue H, Lu XF, Zheng PR, et al. Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile. J Med Chem 2010; 53: 1397-401.
275. Mahajan DH, Pannecouque C, Clercq ED, Chikhalia KH. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-striazine derivatives as potential anti-HIV agents. Arch Pharm Chem Life Sci 2009; 342: 281-90.
276. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenzaA(H1N1): early findings. Science 2009; 324: 1557-61.
277. Iranshahi M, Kalategi F, Rezaee R, et al. Cancer chemopreventive activity of terpenoid coumarins from Ferula species. Planta Med 2008; 74: 147-50.
278. 1) antiviral and cytotoxic agents from Ferula assa-foetida. J Nat Prod 2009; 72: 1568-72.
279. Yeh JY, Coumar MS, Horng JT, et al. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives. J Med Chem 2010; 53: 1519-33.
280. Arango V, Robledo S, Séon-Méniel B, et al. Coumarins from Galipea Panamensis and their activity against Leishmania Panamensis. J Nat Prod 2010; 73: 1012-4.
281. Ferreira ME, Arias ARD, Yaluff G, et al. Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata. Phytomedicine 2010; 17: 375-8.
282. Brenzan MA, Nakamura CV, Dias Filho BP, et al. Structureactivity relationship of (-) mammea A/BB derivatives against Leishmania amazonensis. Biomed Pharmacother 2008; 62: 651-8.
283. Pierson JT, Dumètre A, Hutter S, et al. Synthesis and antiprotozoal activity of 4-arylcoumarins. Eur J Med Chem 2010; 45: 864-9.
284. Hayton K, Su XZ. Drug resistance and genetic mapping in Plasmodium falciparum. Curr Genet 2008; 54: 223-9.
285. Coslédan F, Fraisse L, Pellet A, et al. Selection of a trioxaquine as an antimalarial drug candidate. Proc Natl Acad Sci USA 2008; 105: 17579-84.
286. Sashidhara KV, Kumar A, Dodda RP, et al. Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds. Bioorg Med Chem Lett 2012; 22: 3926-30.
287. Chintakrindi AS, Shaikh MS, Coutinho EC. De novo design of 7-aminocoumarin derivatives as novel falcipain-3 inhibitors. J Mol Model 2012; 18: 1481-93.
288. Patel K, Karthikeyan C, Moorthy NSHN, et al. Design, synthesis and biological evaluation of some novel 3-cinnamoyl-4-hydroxy-2H-chromen-2-ones as antimalarial agents. Med Chem Res 2012; 21: 1780-4.
289. Iqbal PF, Bhat AR, Azam A. Antiamoebic coumarins from the root bark of Adina cordifolia and their new thiosemicarbazone derivatives. Eur J Med Chem 2009; 44: 2252-9.
290. Oliveira de Lima F, Nonato FR, Couto RD, et al. Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin. J Nat Prod 2011; 74: 596-602.
291. Zhang HZ, Zhou CH, Geng RX, Ji QG. Recent advances in syntheses of oxazole compounds. Chin J Org Chem 2011; 31: 1963-76 (in Chinese).
292. Çolak AT, Çolak F, Atar N, Olgun A. Synthesis, spectral, thermal analysis, biological activity and kinetic studies of copper (II)-pyradine-2,5-dicarboxylate complexes with 2-aminomethylpyridine and 8-hydroxyquinoline. Acta Chim Slov 2010; 57: 212-21.
293. Anderluh PŠ, Vilfan G, Prezelj A, Urleb U. Synthesis and C6-ethylidene meropenem derivative with antimicrobial activity. Acta Chim Slov 2009; 56: 669-73.
294. Kang KH, Kong CS, Seo Y, Kim MM, Kim SK. Anti-inflammatory effect of coumarins isolated from Corydalis heterocarpa in HT-29 human colon carcinoma cells. Food Chem Toxicol 2009; 47: 2129-34.
295. Menghini L, Epifano F, Genovese S, Marcotullio MC, Sosa S, Tubaro A. Antiinflammatory activity of coumarins from Ligusticum lucidum Mill. subsp. cuneifolium (Guss.) Tammaro (Apiaceae). Phytother Res 2010; 24: 1697-9.
296. Sandhya B, Giles D, Mathew V, Basavarajaswamy G, Abraham R. Synthesis, pharmacological evaluation and docking studies of coumarin derivatives. Eur J Med Chem 2011; 46: 4696-701.
297. Khode S, Maddi V, Aragade P, et al. Synthesis and pharmacological evaluation of a novel series of 5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents. Eur J Med Chem 2009; 44: 1682-8.
298. Eissa AAM, Farag NAH, Soliman GAH. Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents. Bioorg Med Chem 2009; 17: 5059-70.
299. Keri RS, Hosamani KM, Shingalapur RV, Hugar MH. Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety. Eur J Med Chem 2010; 45: 2597-605.
300. Gupta JK, Sharma PK, Dudhe R, et al. Analgesic study of novel pyrimidine derivatives linked with coumarin moiety. Med Chem Res 2012; 21: 1625-32.
301. Symeonidis T, Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE. Synthesis and anti-inflammatory evaluation of novel angularly or linearly fused coumarins. Eur J Med Chem 2009; 44: 5012-7.
302. Ingale N, Maddi V, Palkar M, et al. Synthesis and evaluation of anti-inflammatory and analgesic activity of 3-[(5-substituted-1,3,4-oxadiazol-2-yl-thio)acetyl]-2H-chromen-2-ones. Med Chem Res 2012; 21: 16-26.
303. Li G., Wang DM, Sun MN, et al. Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice. J Med Chem 2010; 53: 1741-54.
304. Li ZP, Hu JF, Sun MN, et al. Effect of compound IMMLG5521, a novel coumarin derivative, on carrageenan-induced pleurisy in rats. Eur J Pharmacol 2011; 661: 118-23.
305. Li ZP, Hu JF, Sun MN, et al. Anti-inflammatory effect of IMMLG5521, a coumarin derivative, on sephadex-induced lung inflammation in rats. Int Immunopharm 2012; 14: 145-9.
306. Cho JY, Hwang TL, Chang TH, et al. New coumarins and antiin flammatory constituents from Zanthoxylum avicennae. Food Chem 2012; 135: 17-23.
307. Selim YA, Ouf NH. Anti-inflammatory new coumarin from the Ammi majus L. Org Med Chem Lett 2012; 2: 1-4.
308. Timonen JM, Nieminen RM, Sareila O, et al. Synthesis and antiin flammatory effects of a series of novel 7-hydroxycoumarin derivatives. Eur J Med Chem 2011; 46: 3845-50.
309. Behrenswerth A, Volz N, Toräng J, Hinz S, Bräse S, Müller CE. Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists. Bioorg Med Chem 2009; 17: 2842-51.
310. Kalkhambkar RG, Kulkarni GM, Kamanavalli CM, Premkumar N, Asdaq SMB, Sun CM. Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins. Eur J Med Chem 2008; 43: 2178-88.
311. Pandey MK, Balwani S, Sharma PK, Parmar VS, Ghosh B, Watterson AC. Design, synthesis and anti-inflammatory evaluation of PEGylated 4-methyl and 4,8-dimethylcoumarins. Eur J Pharm Sci 2010; 39: 134-40.
312. Thongthoom T, Songsiang U, Phaosiri C, Yenjai C. Biological activity of the chemical constituents from Clausena harmandiana. Arch Pharm Res 2010; 33: 675-80.
313. Noipha K, Thongthoom T, Songsiang U, Boonyarat C, Yenjai C. Carbazoles and coumarins from Clausena harmandiana stimulate glucose uptake in L6 myotubes. Diabetes Res Clin Pr 2010; 90: e67-71.
314. Dwivedi AP, Kumar S, Varshney V, Singh AB, Srivastava AK, Sahu DP. Synthesis and antihyperglycemic activity of novel Nacyl-2-arylethylamines and N-acyl-3-coumarylamines. Bioorg Med Chem Lett 2008; 18: 2301-5.
315. Tegginamath G, Kamble RR, Kattimani PP, Margankop SB. Synthesis of 3-aryl-4-({2-[4-(6-substituted-coumarin-3-yl)-1,3-thiazol-2-yl]hydrazinylidene}methyl/ethyl)-sydnones using silica sulfuric acid and their antidiabetic, DNA cleavage activity. Arabian J Chem 2011; doi: 10.1016/j.arabjc.2011.04.006.
316. Slamova K, Marhol P, Bezouska K, et al. Synthesis and biological activity of glycosyl-1H-1,2,3-triazoles. Bioorg Med Chem Lett 2010; 20: 4263-5.
317. Ferreira SB, Sodero ACR, Cardoso MFC, et al. Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as α-glucosidase inhibitors. J Med Chem 2010; 53: 2364-74.
318. Anand N, Jaiswal N, Pandey SK, Srivastava AK, Tripathi RP. Application of click chemistry towards an effcient synthesis of 1,2,3-1H-triazolyl glycohybrids as enzyme inhibitors. Carbohydr Res 2011; 346: 16-25.
319. Kini D, Ghate M. Synthesis and oral hypoglycemic activity of 3-[5'-methyl-2'-aryl-3'-(thiazol-2''-yl amino) thiazolidin-4'-one]coumarin derivatives. E-J Chem 2011; 8: 386-90.
320. Belmaker RH, Agam G. Major depressive disorder. Engl J Med 2008; 358: 55-68.
321. Sashidhara KV, Rosaiah JN, Bhatia G, Saxena JK. Novel ketoenamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2Hbenzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents. Eur J Med Chem 2008; 43: 2592-6.
322. Capra JC, Cunha MP, Machado DG, et al. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. Eur J Pharmacol 2010; 643: 232-8.
323. Pahari P, Rohr J. Total synthesis of psoralidin, an anticancer natural product. J Org Chem 2009; 74: 2750-4.
324. Yi LT, Li YC, Pan Y, et al. Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea corylifolia in the forced swimming test in mice. Progr Neuropsychopharmacol Biol Psychiatr 2008; 32: 510-9.
325. Chen YC, Cheung YT, Kong LD, et al. Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia. Life Sci 2008; 82: 1117-21.
326. Sashidhara KV, Kumar A, Chatterjee M, et al. Discovery and synthesis of novel 3-phenylcoumarin derivatives as antidepressant agents. Bioorg Med Chem Lett 2011; 21: 1937-41.
327. Vergel NE, López JL, Orallo F, et al. Antidepressant-like profile and MAO-A inhibitory activity of 4-propyl-2H-benzo[h]-chromen-2-one. Life Sci 2010; 86: 819-24.
328. Amin KM, Rahman DEA, Al-Eryani YA. Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents. Bioorg Med Chem 2008; 16: 5377-88.
329. Gan LL, Cai JL, Zhou CH. Advances in the research of piperazine compounds as receptor ligands. Chin Pharma J 2009; 44: 1361-8 (in Chinese).
330. Gan LL, Lu YH, Zhou CH. Advances in the research of piperazine compounds as enzyme inhibitors. Chin J Biochem Pharm 2009; 30: 127-31 (in Chinese).
331. Cai JL, Lu YH, Gan LL, Zhang YY, Zhou CH. Recent advance in the research of piperazine-containing compounds as antimicrobial agents. Chin J Antibiot 2009; 34: 454-62 (in Chinese).
332. Gan LL, Zhou CH. Synthesis of azole-containing piperazine derivatives and evaluation of their antibacterial, antifungal and cytotoxic activities. Bull Korean Chem Soc 2010; 31: 3684-92.
333. Wang XL, Gan LL, Yan CY, Zhou CH. Synthesis and their evaluation for their antimicrobial activity of diphenyl piperazine-based sulfanilamides. Scientia Sinica Chimica 2011; 41: 451-60 (in Chinese).
334. 1-antihistaminic agents. Bioorg Med Chem 2008; 16: 9009-17.
335. Sashidhara KV, Kumar A, Kumar M, Sonkar R, Bhatia G, Khanna AK. Novel coumarin derivatives as potential antidyslipidemic agents. Bioorg Med Chem Lett 2010; 20: 4248-51.
336. Sashidhara KV, Kumar A, Kumar M, Srivastava A, Puri A. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives. Bioorg Med Chem Lett 2010; 20: 6504-7.
337. Steed JW, Atwood JL, Gale PA. Definition and emergence of supramolecular chemistry. Supramol Chem 2012; 1: 3-7.
338. Zhou CH, Gan LL, Zhang YY, et al. Review on supermolecules as chemical drugs. Sci China Ser B: Chem 2009; 52: 415-58.
339. Kharadi GJ, Patel KD. Antibacterial, spectral and thermal aspects of drug based-Cu(II) mixed ligand complexes. Appl Organometal Chem 2009; 23: 391-7.
340. Kharadi GJ, Patel KD. In-vitro antimicrobial, thermal and spectral studies of mixed ligand Cu(II) heterochelates of clioquinol and coumarin derivatives. Appl Organometal Chem 2010; 24: 332-7.
341. Mirkhani V, Moghadam M, Tangestaninejad S, Mohammadpoor-Baltork I, Shams E, Rasouli N. Catalytic epoxidation of olefins with hydrogen peroxide by hybrid complex containing nickel(III) Schiff base complex covalently linked to polyoxometalate. Appl Catal A 2008; 334: 106-11.
342. Keskioglu E, Gunduzalp AB, Cete S, Hamurcu F, Erk B. Cr(III), Fe(III) and Co(III) complexes of tetradentate (ONNO) Schiff base ligands: synthesis, characterization, properties and biological activity. Spectrochim Acta 2008; 70A: 634-40.
343. Jani GR, Vyas KB, Franco Z. Preparation and antimicrobial activity of s-triazine hydrazones of 7-hydroxy coumarin and their metal complexes. E-J Chem 2009; 6: 1228-32.
344. Geweely NS. Novel inhibition of some pathogenic fungal and bacterial species by new synthetic phytochemical coumarin derivatives. Ann Microbiol 2009; 59: 359-68.
345. Phaniband MA, Dhumwad SD, Pattan SR. Synthesis, characterization, antimicrobial, and DNA cleavage studies of metal complexes of coumarin Schiff bases. Med Chem Res 2011; 20: 493-502.
346. Patil SA, Unki SN, Badami PS. Synthesis, characterization, biological and thermal behaviour of Co(II), Ni(II) and Cu(II) complexes with Schiff bases having coumarin moieties. J Therm Anal Calorim 2013; 111: 1281-9.
347. Patil SA, Unki SN, Badami PS. In vitro antibacterial, antifungal, and DNA cleavage studies of coumarin Schiff bases and their metal complexes: synthesis and spectral characterization. Med Chem Res 2012; 21: 4017-27.
348. Creaven BS, Devereux M, Karcz D, et al. Copper(II) complexes of coumarin-derived Schiff bases and their anti-Candida activity. J Inorg Biochem 2009; 103: 1196-203.
349. Mosaa AI, Emara AAA, Yousef JM, Saddiq AA. Novel transition metal complexes of 4-hydroxy-coumarin-3-thiocarbohydrazone: pharmacodynamic of Co(III) on rats and antimicrobial activity. Spectrochim Acta, Part A 2011; 81: 35-43.
350. Patil SA, Unki SN, Kulkarni AD, Naik VH, Badami PS. Co(II), Ni(II) and Cu(II) complexes with coumarin-8-yl Schiff-bases: Spectroscopic, in vitro antimicrobial, DNA cleavage and uorescence studies. Spectrochim Acta 2011; 79A: 1128-36.
351. Refat MS, El-Deen IM, Anwer ZM, El-Ghol S. Bivalent transition metal complexes of coumarin-3-yl thiosemicarbazone derivatives: spectroscopic, antibacterial activity and thermogravimetric studies. J Mol Struct 2009; 20: 149-62.
352. Patil SA, Naik VH, Kulkarni AD, Badami PS. DNA cleavage, antimicrobial, spectroscopic and uorescence studies of Co(II), Ni(II) and Cu(II) complexes with SNO donor coumarin Schiff bases. Spectrochim Acta 2010; 75A: 347-54.
353. Bagihalli GB, Avaji PG, Patil SA, Badami PS. Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. Eur J Med Chem 2008; 43: 2639-49.
354. Patil SA, Unki SN, Kulkarni AD, Naik VH, Badami PS. Synthesis, characterization, in vitro antimicrobial and DNA cleavage studies of Co(II), Ni(II) and Cu(II) complexes with ONOO donor coumarin Schiff bases. J Mol Struct 2011; 985: 330-8.
355. Kapoor P, Fahmi N, Singh RV. Microwave assisted synthesis, spectroscopic, electrochemical and DNA cleavage studies of Lanthanide(III) complexes with coumarin based imines. Spectrochim Acta 2011; 83A: 74-81.
356. Kulkarni A, Patil SA, Badami PS. Synthesis, characterization, DNA cleavage and in vitro antimicrobial studies of La(III), Th(IV) and VO(IV) complexes with Schiff bases of coumarin derivatives. Eur J Med Chem 2009; 44: 2904-12.
357. Datta P, Mukhopadhyay AP, Manna P, Tiekink ERT, Sil PC, Sinha C. Structure, photophysics, electrochemistry, DFT calculation, and in-vitro antioxidant activity of coumarin Schiff base complexes of group 6 metal carbonyls. J Inorg Biochem 2011; 105: 577-88.
358. Kharadi GJ. Antitubercular and fluorescence studies of copper(II) complexes with quinolone family member, ciprofloxacin. Spectrochim Acta 2011; 79A: 898-903.
359. Kharadi GJ, Patel KD. Synthesis, spectroscopic, thermal and biological aspect of mixed ligand copper(II) complexes. J Therm Anal Calorim 2009; 96: 1019-28.
360. Patel KS, Patel JC, Dholariya HR, Patel KD. Multiple heating rate kinetic parameters, thermal, X-ray diffraction studies of newly synthesized octahedral copper complexes based on bromo-coumarins along with their antioxidant, anti-tubercular and antimicrobial activity evaluation. Spectrochim Acta 2012; 96A: 468-79.
361. Gudasi KB, Patil MS, Vadavi RS. Synthesis, characterization of copper(II), cobalt(II), nickel(II), zinc(II) and cadmium(II) complexes of [7-hydroxy-4-methyl-8-coumarinyl]glycine and a comparitive study of their microbial activities. Eur J Med Chem 2008; 43: 2436-41.
362. Harpstrite SE, Prior JL, Rath NP, Sharma V. Metallophrobes: synthesis, characterisation, and potency of a novel gallium(III) complex in human epidermal carcinoma cells. J Inorg Biochem 2007; 101: 1347-53.
363. Creaven BS, Czeglédi E, Devereux M, et al. Biological activity and coordination modes of copper(II) complexes of Schiff base-derived coumarin ligands. Dalton Trans 2010; 39: 10854-65.
364. Thati B, Noble A, Creaven BS, et al. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells. Eur J Pharmacol 2009; 602: 203-14.
365. Milanova M, Zaharieva J, Manolov I, Getzova M, Todorovsky D. Lanthanide complexes with LL-diketones and coumarin derivates: synthesis, thermal behaviour, optical and pharmacological properties and immobilization. J Rare Earths 2010; 28: 66-74.
366. Misra SK, Varma A, Mishra AK. Diagnostic agents-types and applications: a discussion. Rasayan J Chem 2011; 4: 492-7.
367. Signore G, Nifosì R, Albertazzi L, Storti B, Bizzarri R. Polaritysensitive coumarins tailored to live cell imaging. J Am Chem Soc 2010; 132: 1276-88.
368. Dillingham MS, Tibbles KL, Hunter JL, Bell JC, Kowalczykowski SC, Webb MR. Fluorescent single-stranded DNA binding protein as a probe for sensitive, real-time assays of helicase activity. Biophys J 2008; 95: 3330-9.
369. Katritzky AR, Cusido J, Narindoshvili T. Monosaccharide-based water-soluble fluorescent tags. Bioconjugate Chem 2008; 19: 1471-5.
370. McConnell AJ, Beer PD. Heteroditopic receptors for ion-pair recognition. Angew Chem Int Ed 2012; 51: 5052-61.
371. Bian N, Chen Q, Qiu XL, Qi AD, Han BH. Imidazole-bearing tetraphenylethylene: uorescent probe for metal ions based on AIE feature. New J Chem 2011; 35: 1667-71.
372. Zhang ZG, Schreiner PR. (Thio)urea organocatalysis-What can be learnt from anion recognition? Chem Soc Rev 2009; 38: 1187-98.
373. Chang JJ, Wang Y, Zhang HZ, Zhou CH, Geng RX, Ji QG. Recent advances in researches of triazole-based supramolecular chemistry and medicinal drugs. Chem J Chin Univ 2011; 32: 1970-85 (in Chinese).
374. Uhlenheuer DA, Petkau K, Brunsveld L. Combining supramolecular chemistry with biology. Chem Soc Rev 2010; 39: 2817-26.
375. Que EL, Domaille DW, Chang CJ. Metals in neurobiology: probing their chemistry and biology with molecular imaging. Chem Rev 2008; 108: 1517-49.
376. 2+-selective fluorescent chemosensor for imaging copper(II) in HEPG-2 cell. Chem Lett 2008; 37: 462-3.
377. 2+dynamic exchange. Org Lett 2008; 10: 3801-4.
378. 2+-selective fluorescence sensor: synthesis, mechanisms, and applications in living cells. J Am Chem Soc 2009; 131: 2008-12.
379. 2+in living cells. New J Chem 2010; 34: 1055-8.
380. 2+chemodosimeters and the applications for living cell imaging. Org Lett 2012; 14: 432-5.
381. Taki M, Desaki M, Ojida A, et al. Fluorescence imaging of intracellular cadmium using a dual-excitation ratiometric chemosensor. J Am Chem Soc 2008; 130: 12564-5.
382. Amendola V, Fabbrizzi L. Anion receptors that contain metals as structural units. Chem Commun 2009; 513-31.
383. Kurishita Y, Kohira T, Ojida A, Hamachi I. Rational design of FRET-based ratiometric chemosensors for in vitro and in cell fluorescence analyses of nucleoside polyphosphates. J Am Chem Soc 2010; 132: 13290-9.
384. Zhou Y, Liu K, Li JY, Fang Y, Zhao TC, Yao C. Visualization of nitroxyl in living cells by a chelated copper(II) coumarin complex. Org Lett 2011; 13: 1290-3.
385. Li S, Zhou CH, Chen JX, Xiang QX. Ethidium bromide fluorescence probe on the interaction between dinuclear macrocyclic polyamine Zn(II) complex and DNA. Chin J Appl Chem 2009; 26: 1461-5 (in Chinese).
386. Worono G, El Harrak A, Mayot E, et al. New generation of amino coumarin methyl sulfonate-based fluorogenic substrates for amidase assays in droplet-based microfluidic applications. Anal Chem 2011; 83: 2852-7.
387. Agnes RS, Jernigan F, Shell JR, Sharma V, Lawrence DS. Suborganelle sensing of mitochondrial cAMP-dependent protein kinase activity. J Am Chem Soc 2010; 132: 6075-80.
388. Carlucci A, Lignitto L, Feliciello A. Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome. Trends Cell Biol 2008; 18: 604-13.
389. Kikuchi K, Hashimoto S, Mizukami S, Nagano T. Anion sensorbased ratiometric peptide probe for protein kinase activity. Org Lett 2009; 11: 2732-5.
390. Li YH, Wang H, Li J, Zheng J, Xu XH, Yang RH. Simultaneous intracellular β-D-glucosidase and phosphodiesterase I activities measurements based on a triple-signaling fluorescent probe. Anal Chem 2011; 83: 1268-74.
391. Holmes CP, Macher N, Grove JR, Jang L, Irvine JD. Designing better coumarin-based fluorogenic substrates for PTP1B. Bioorg Med Chem Lett 2008; 18: 3382-5.
392. Huang ST, Teng CJ, Lee YH, Wu JY, Wang KL, Lin CM. Design and synthesis of a long-wavelength latent fluorogenic substrate for salicylate hydroxylase: a useful fluorimetric indicator for analyte determination by dehydrogenase-coupled biosensors. Anal Chem 2010; 82: 7329-34.
393. Smith BA, O'Neil EJ, Lampkins AJ, et al. Evaluation of fluorescent phosphatidylserine substrates for the aminophospholipid flippase in mammalian cells. J Fluoresc 2012; 22: 93-101.
394. Zhou XM, Graham TR. Reconstitution of phospholipids translocase activity with purified Drs2p, a type-IV P-type ATPase from budding yeast. Proc Natl Acad Sci USA 2009; 106: 16586-91.
395. Coleman JA, Kwok MCM, Molday RS. Localization, purification, and functional reconstitution of the P4-ATPase Atp8a2, a phosphatidylserine flippase in photoreceptor disc membranes. J Biol Chem 2009; 284: 32670-9.
396. +-pump. Biochim Biophys Acta 2009; 1791: 603-11.
397. Long SB, Chen L, Xiang YM, Song MG, Zheng YG, Zhu Q. An activity-based fluorogenic probe for sensitive and selective monoamine oxidase-B detection. Chem Commun 2012; 48: 7164-6.
398. Watzke A, Kosec G, Kindermann M, et al. Selective activity-based probes for cysteine cathepsins. Angew Chem Int Ed 2008; 47: 406-9.
399. Welser K, Grilj J, Vauthey E, Aylott JW, Chan WC. Protease responsive nanoprobes with tethered fluorogenic peptidyl 3-arylcoumarin substrates. Chem Commun 2009; 671-3.
400. Chen XQ, Zhou Y, Peng XJ, Yoon J. Fluorescent and colorimetric probes for detection of thiols. Chem Soc Rev 2010; 39: 2120-35.
401. Antelmann H, Helmann JD. Thiol-based redox switches and gene regulation. Antioxid Redox Signal 2010; 14: 1049-63.
402. Paulsen CE, Carroll KS. Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol 2009; 5: 47-62.
403. Lin J, Lee IM, Song YQ, et al. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res 2010; 70: 2397-405.
404. Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010; 29: 405-34.
405. Gupta D, Griendling KK, Taylor RW. Oxidative stress and cardiovascular disease in diabetes mellitus. In Sauer H, Shah AM, Laurindo FRM. Eds. Studies on cardiovascular disorders. Humana Press: New York 2010; pp. 263-79.
406. Salmon AB, Richardson A, Pérez VI. Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging? Free Radic Biol Med 2010; 48: 642-55.
407. Yao ZY, Bai H, Li C, Shi GQ. Colorimetric and fluorescent dual probe based on a polythiophene derivative for the detection of cysteine and homocysteine. Chem Commun 2011; 47: 7431-3.
408. Jung HS, Ko KC, Kim GH, et al. Coumarin-based thiol chemosensor: synthesis, turn-on mechanism, and its biological application. Org Lett 2011; 13: 1498-501.
409. Zhao WA, Brook MA, Li YF. Design of gold nanoparticle-based colorimetric biosensing assays. ChemBioChem 2008; 9; 2363-71.
410. Zhou X, Jin XJ, Sun GY, Li DH, Wu X. A cysteine probe with high selectivity and sensitivity promoted by response-assisted electrostatic attraction. Chem Commun 2012; 48: 8793-5.
411. Kim GJ, Lee K, Kwon H, Kim HJ. Ratiometric fluorescence imaging of cellular glutathione. Org Lett 2011; 13: 2799-801.
412. Lee KS, Kim TK, Lee JH, Kim HJ, Hong JI. Fluorescence turn-on probe for homocysteine and cysteine in water. Chem Commun 2008; 6173-5.
413. Sun YQ, Chen ML, Liu J, Lv X, Li JF, Guo W. Nitroolefln-based coumarin as a colorimetric and fluorescent dual probe for biothiols. Chem Commun 2011; 47: 11029-31.
414. Reddie KG, Humphries WH, Bain CP, Payne CK, Kemp ML, Murthy N. Fluorescent coumarin thiols measure biological redox couples. Org Lett 2012; 14: 680-3.
415. García-Beltrán O, Mena N, Pérez EG, et al. The development of a fluorescence turn-on sensor for cysteine, glutathione and other biothiols. A kinetic study. Tetrahedron Lett 2011; 52: 6606-9.
416. Yuan L, Lin WY, Song JZ. Ratiometric fluorescent detection of intracellular hydroxyl radicals based on a hybrid coumarin-cyanine platform. Chem Commun 2010; 46: 7930-2.
417. Hirosawa S, Arai S, Takeoka S. A TEMPO-conjugated fluorescent probe for monitoring mitochondrial redox reactions. Chem Commun 2012; 48: 4845-7.
418. Signore G, Nifosì R, Albertazzi L, Storti B, Bizzarri R. Polaritysensitive coumarins tailored to live cell imaging. J Am Chem Soc 2010; 132: 1276-88.
419. Plajnšek KT, Pajk S, Govedarica B, Pečar S, Srčič S, Kristl J. A novel fluorescent probe for more effective monitoring of nanosized drug delivery systems within the cells. Int J Pharm 2011; 416: 384-93.
420. Hanes JW, Chatterjee D, Soriano EV, Ealick SE, Begley TP. Construction of a thiamin sensor from the periplasmic thiamin binding protein. Chem Commun 2011; 47: 2273-5.
421. Agostinelli E, Marques MPM, Calheiros R, et al. Polyamines: fundamental characters in chemistry and biology. Amino Acids 2010; 38: 393-403.
422. Lee B, Scopelliti R, Severin K. A molecular probe for the optical detection of biogenic amines. Chem Commun 2011; 47: 9639-41.
423. Kovalska VB, Volkova KD, Manaev AV, et al. 2-Quinolone and coumarin polymethines for the detection of proteins using fluorescence. Dyes Pigments 2010; 84: 159-64.
424. Prentoe P. Staining of macromolecules: possible mechanisms and examples. Biotech Histochem 2009; 84: 139-58.
425. Cui SF, Wang Y, Lv JS, Damu GLV, Zhou CH. Recent advances in application researches of thiazole compounds. Scientia Sinica Chimica 2012; 42: 1105-31 (in Chinese).
426. Karton-Lifshin N, Segal E, Omer L, Portnoy M, Satchi-Fainaro R, Shabat D. A unique paradigmfor a turn-on near-infrared cyaninebased probe: noninvasive intravital optical imaging of hydrogen peroxide. J Am Chem Soc 2011; 133: 10960-5.
427. Wang CN, Wu CY, Zhu JQ, Miller RH, Wang YM. Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination. J Med Chem 2011; 54: 2331-40.
428. Frullano L, Zhu JQ, Wang CN, Wu CY, Miller RH, Wang YM. Myelin imaging compound (MIC) enhanced magnetic resonance imaging of myelination. J Med Chem 2012; 55: 94-105.